Ok, everyone, let's be very conservative here. If
Post# of 36537
(Total Views: 386)
Posted On: 11/20/2021 4:06:39 AM
Ok, everyone, let's be very conservative here.
If nothing else works, especially - pessimisticly speaking - the vaccine in the end is not being approved by the FDA, GNBT will still have Excellagen. Even in the CC in May they laid out a clear plan on how to rule out and make Excellegen a commercial success. This is months ago, and for sure these guys working at Olaregen have not sit n silence and did not work hard to turn the described plan into reality.
From all I have heard Excellegen sounds like a license to print money, especially when this is roled out internationally. So only from this perspective, and if nothing else would work, within a year this alone should justify share prices of several dollars.
If they then use part of this revenue to get the Oral-lyn phase 3 trials started again, and final close the deal on AltuCell then we already have a very prosperous Biotech company without even looking at NGIO, which ADDITIONALLY is conservatively valued with $500 mill. with little to no vaccine value priced into that number.
But if GNBT is already starting to generate significant cashflow from the Excellegen sales, it is beyond me as to why the CompleteVaccine development and clinical trials should not be completed and successful. And that Covid is not going to go away any time soon, and other more potent and long term effective vaccines are needed, is right now getting clearer to us all at lest here in Central Europe (Austria has just declared the next hard lockdown, even though 70+% of the population is vaccinated twice; we here in Germany have record high numbers of new infections almost daily and incidents rates higher than ever, and a similar 70% full vaccination percentage).
So with all that said, I don't see how and why this company would not prosper in the future, even though I don't have a real answer for the continued CompleteSilence neither. But I am still sure as I can be in the current situation that this company is not going under.
So let's wait and see what information we will be provided with one the silence is broken by the company's management. I am sure that thsey will have a good explanation for that when the time is right.
Have a great weekend everyone.
If nothing else works, especially - pessimisticly speaking - the vaccine in the end is not being approved by the FDA, GNBT will still have Excellagen. Even in the CC in May they laid out a clear plan on how to rule out and make Excellegen a commercial success. This is months ago, and for sure these guys working at Olaregen have not sit n silence and did not work hard to turn the described plan into reality.
From all I have heard Excellegen sounds like a license to print money, especially when this is roled out internationally. So only from this perspective, and if nothing else would work, within a year this alone should justify share prices of several dollars.
If they then use part of this revenue to get the Oral-lyn phase 3 trials started again, and final close the deal on AltuCell then we already have a very prosperous Biotech company without even looking at NGIO, which ADDITIONALLY is conservatively valued with $500 mill. with little to no vaccine value priced into that number.
But if GNBT is already starting to generate significant cashflow from the Excellegen sales, it is beyond me as to why the CompleteVaccine development and clinical trials should not be completed and successful. And that Covid is not going to go away any time soon, and other more potent and long term effective vaccines are needed, is right now getting clearer to us all at lest here in Central Europe (Austria has just declared the next hard lockdown, even though 70+% of the population is vaccinated twice; we here in Germany have record high numbers of new infections almost daily and incidents rates higher than ever, and a similar 70% full vaccination percentage).
So with all that said, I don't see how and why this company would not prosper in the future, even though I don't have a real answer for the continued CompleteSilence neither. But I am still sure as I can be in the current situation that this company is not going under.
So let's wait and see what information we will be provided with one the silence is broken by the company's management. I am sure that thsey will have a good explanation for that when the time is right.
Have a great weekend everyone.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼